ABC
IOVA icon

Associated Banc-Corp’s Iovance Biotherapeutics IOVA Stock Holding History

Associated Banc-Corp’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32
Closed -$1K – 579
2020
Q4 		$1K Hold
32
– – ﹤0.01% 924
2020
Q3 		$1K Sell
32
-12
-27% -$368 ﹤0.01% 886
2020
Q2 		$1K Sell
44
-3
-6% -$99 ﹤0.01% 863
2020
Q1 		$1K Buy
+47
New +$1.25K ﹤0.01% 812

Other funds holding IOVA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Associated Banc-Corp's IOVA Position: Q1 2021 in Review

Associated Banc-Corp sold out of Iovance Biotherapeutics (IOVA) in Q1 2021, closing a stake of 32 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in IOVA in Q1 2020 and held it in 4 quarters. The position peaked at $1K in Q4 2020. 252 funds tracked by Wall St. Rank hold IOVA as of Q1 2021.

  • Associated Banc-Corp reported no remaining Iovance Biotherapeutics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 32 Iovance Biotherapeutics shares in Q1 2021, an estimated $1K.
  • Associated Banc-Corp first reported a position in Iovance Biotherapeutics in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Iovance Biotherapeutics position peaked at $1K in Q4 2020.
  • 252 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.